These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 3827837
21. Location of the antithrombin-binding sequence in the heparin chain. Oscarsson LG, Pejler G, Lindahl U. J Biol Chem; 1989 Jan 05; 264(1):296-304. PubMed ID: 2909522 [Abstract] [Full Text] [Related]
22. Behavior of antithrombin III isoforms on immobilized heparins. Evidence that the isoforms bind to different numbers of low-affinity heparin sites. Carlson TH, Babcock T, Atencio AC, Levinson C, Mora HR. J Biol Chem; 1988 Feb 15; 263(5):2187-94. PubMed ID: 3339006 [Abstract] [Full Text] [Related]
23. Implications of Heparanase on Heparin Synthesis and Metabolism in Mast Cells. Maccarana M, Jia J, Li H, Zhang X, Vlodavsky I, Li JP. Int J Mol Sci; 2022 Apr 27; 23(9):. PubMed ID: 35563215 [Abstract] [Full Text] [Related]
24. Age-related changes in the chemical composition of bovine articular cartilage. The structure of high-density proteoglycans. Garg HG, Swann DA. Biochem J; 1981 Feb 01; 193(2):459-68. PubMed ID: 6796048 [Abstract] [Full Text] [Related]
25. The molecular-weight-dependence of the anti-coagulant activity of heparin. Laurent TC, Tengblad A, Thunberg L, Höök M, Lindahl U. Biochem J; 1978 Nov 01; 175(2):691-701. PubMed ID: 743219 [Abstract] [Full Text] [Related]
26. High and low anticoagulant activity heparins. Preparation in large scale and degree of complexation with antithrombin III. Takahashi HK, Nader HB, Dietrich CP. Arzneimittelforschung; 1985 Nov 01; 35(11):1620-3. PubMed ID: 4091864 [Abstract] [Full Text] [Related]
27. Isolation of 35S- and 3H-labelled proteoglycans from cultures of human embryonic skin fibroblasts. Cöster L, Carlstedt I, Malmström A. Biochem J; 1979 Dec 01; 183(3):669-81. PubMed ID: 120197 [Abstract] [Full Text] [Related]
28. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography. Bianchini P, Osima B, Parma B, Nader HB, Dietrich CP. J Pharmacol Exp Ther; 1982 Feb 01; 220(2):406-10. PubMed ID: 7057400 [Abstract] [Full Text] [Related]
29. Structural differences between heparan sulphates of proteoglycan involved in the formation of basement membranes in vivo by Lewis-lung-carcinoma-derived cloned cells with different metastatic potentials. Nakanishi H, Oguri K, Yoshida K, Itano N, Takenaga K, Kazama T, Yoshida A, Okayama M. Biochem J; 1992 Nov 15; 288 ( Pt 1)(Pt 1):215-24. PubMed ID: 1445266 [Abstract] [Full Text] [Related]
30. Enzymic depolymerization of macromolecular heparin as a factor in control of lipoprotein lipase activity. Horner AA. Proc Natl Acad Sci U S A; 1972 Nov 15; 69(11):3469-73. PubMed ID: 4508335 [Abstract] [Full Text] [Related]
31. Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Lindahl U, Bäckström G, Thunberg L, Leder IG. Proc Natl Acad Sci U S A; 1980 Nov 15; 77(11):6551-5. PubMed ID: 6935668 [Abstract] [Full Text] [Related]
32. Native heparin from rat peritoneal mast cells. Yurt RW, Leid RW, Austen KF. J Biol Chem; 1977 Jan 25; 252(2):518-21. PubMed ID: 833141 [Abstract] [Full Text] [Related]
33. Purification and characterization of human platelet proteoglycan. Okayama M, Oguri K, Fujiwara Y, Nakanishi H, Yonekura H, Kondo T, Ui N. Biochem J; 1986 Jan 01; 233(1):73-81. PubMed ID: 3954736 [Abstract] [Full Text] [Related]
34. Comparison of the separation of bovine heparin by strong anion exchange and by gel filtration chromatography. Rosenfeld L, Prior MT, Girardi LM. Thromb Res; 1991 Oct 15; 64(2):203-11. PubMed ID: 1811339 [Abstract] [Full Text] [Related]
35. A fragment of antithrombin that binds both heparin and thrombin. Rosenfeld L, Danishefsky I. Biochem J; 1986 Aug 01; 237(3):639-46. PubMed ID: 3800906 [Abstract] [Full Text] [Related]
36. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins. Azhar A, Singh P, Rashid Q, Naseem A, Khan MS, Jairajpuri MA. Protein Pept Lett; 2013 Apr 01; 20(4):403-11. PubMed ID: 23016581 [Abstract] [Full Text] [Related]
37. Identification of chondroitin sulfate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cells. Stevens RL, Fox CC, Lichtenstein LM, Austen KF. Proc Natl Acad Sci U S A; 1988 Apr 01; 85(7):2284-7. PubMed ID: 3353378 [Abstract] [Full Text] [Related]
38. Proteoglycans of the human intervertebral disc. Electrophoretic heterogeneity of the aggregating proteoglycans of the nucleus pulposus. Jahnke MR, McDevitt CA. Biochem J; 1988 Apr 15; 251(2):347-56. PubMed ID: 3041961 [Abstract] [Full Text] [Related]
39. In silico discovery of a compound with nanomolar affinity to antithrombin causing partial activation and increased heparin affinity. Navarro-Fernández J, Pérez-Sánchez H, Martínez-Martínez I, Meliciani I, Guerrero JA, Vicente V, Corral J, Wenzel W. J Med Chem; 2012 Jul 26; 55(14):6403-12. PubMed ID: 22742452 [Abstract] [Full Text] [Related]
40. Anticoagulant activity of heparin: isolation of antithrombin-binding sites. Hopwood J, Höök M, Linker A, Lindahl U. FEBS Lett; 1976 Oct 15; 69(1):51-4. PubMed ID: 992045 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]